We are live on
!
Find out more
BFO
Boston Family Office Portfolio holdings
AUM
$1.5B
1-Year Est. Return
11.68%
This Fund
S&P 500
This Quarter
Est. Return
+9.91%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$1.1B
AUM Growth
+$73.5M
(+7.1%)
Cap. Flow
-$16.3M
Cap. Flow
% of AUM
-1.48%
Top 10 Holdings %
Top 10 Hldgs %
28.91%
Holding
248
New
4
Increased
56
Reduced
116
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zebra Technologies
ZBRA
|
+$2.39M |
| 2 |
AbbVie
ABBV
|
+$1.05M |
| 3 |
Stryker
SYK
|
+$910K |
| 4 |
Air Products & Chemicals
APD
|
+$856K |
| 5 |
Relay Therapeutics
RLAY
|
+$805K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.51M |
| 2 |
Middleby
MIDD
|
+$2.65M |
| 3 |
MRSH
Marsh
MRSH
|
+$1.4M |
| 4 |
Amazon
AMZN
|
+$1.02M |
| 5 |
Aflac
AFL
|
+$1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.19% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 9.14% |
| 4 | Industrials | 8.55% |
| 5 | Consumer Discretionary | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Saic
SAIC
$5.35B
| $214K | 0.02% |
2,735
| – | – |
|
227
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $211K | 0.02% |
+3,990
| New | +$209K |
|
228
Wabtec
WAB
$49.2B
| $201K | 0.02% |
3,245
-2,093
| -39% | -$134K |
|
229
Primis Financial Corp
FRST
$400M
| $199K | 0.02% |
22,900
| – | – |
|
230
GE Aerospace
GE
$380B
| $175K | 0.02% |
5,639
+426
| +8% | +$13.8K |
|
231
Antero Midstream
AM
$10.4B
| $81K | 0.01% |
15,000
| – | – |
|
232
Globalstar
GSAT
$10.9B
| $3K | ﹤0.01% |
667
| – | – |
|
233
ICU Medical
ICUI
$4.61B
| – | – |
-4,500
| Closed | -$829K |
|
234
Newmont
NEM
$122B
| – | – |
-3,500
| Closed | -$216K |
|
235
SLB Ltd
SLB
$78B
| – | – |
-15,026
| Closed | -$276K |
|
236
T. Rowe Price
TROW
$24.4B
| – | – |
-2,033
| Closed | -$251K |
|
237
UGI
UGI
$7.27B
| – | – |
-7,000
| Closed | -$223K |
|
238
Valero Energy
VLO
$90.3B
| – | – |
-4,573
| Closed | -$269K |
|
239
Wells Fargo
WFC
$264B
| – | – |
-8,256
| Closed | -$211K |
|
240
W.P. Carey
WPC
$16.1B
| – | – |
-4,120
| Closed | -$273K |
|
|
CATC
241
DELISTED
CAMBRIDGE BANCORP
CATC
| – | – |
-3,679
| Closed | -$218K |
|
|
COHR
242
DELISTED
Coherent Inc
COHR
| – | – |
-2,702
| Closed | -$354K |
|
Similar funds
CP
AAM
TP
NSGL
SGM
RG
CPA
MCM
Boston Family Office's Q3 2020 Portfolio in Review
As of Q3 2020, Boston Family Office held 248 positions worth $1.1B, up 7.1% from $1.03B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Boston Family Office's Q3 2020 filing shows 4 new, 56 increased, 116 reduced and 11 closed positions. Its largest new stake was Relay Therapeutics: 21,121 shares worth $900K. The largest sale was Apple, an estimated $4.51M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Boston Family Office's largest Q3 2020 buy was Relay Therapeutics: 21,121 shares worth $900K.
- Boston Family Office added most to Zebra Technologies in Q3 2020, an estimated $2.39M increase.
- Boston Family Office's biggest Q3 2020 reduction was Apple, cutting an estimated $4.51M.
- Boston Family Office fully exited ICU Medical in Q3 2020, selling an estimated $829K.
- Boston Family Office's ten largest holdings make up 29% of its $1.1B portfolio in Q3 2020.
- Boston Family Office opened 4 new positions and closed 11 in Q3 2020.
- Boston Family Office's portfolio value rose 7.1% quarter-over-quarter to $1.1B.
Based on Boston Family Office's 13F filing for Q3 2020, filed 10 Nov 2020.